ARS Pharmaceuticals Statistics
Total Valuation
SPRY has a market cap or net worth of $412.71 million. The enterprise value is $440.46 million.
| Market Cap | 412.71M |
| Enterprise Value | 440.46M |
Important Dates
The last earnings date was Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SPRY has 99.45 million shares outstanding. The number of shares has increased by 1.43% in one year.
| Current Share Class | 99.45M |
| Shares Outstanding | 99.45M |
| Shares Change (YoY) | +1.43% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 6.15% |
| Owned by Institutions (%) | 57.10% |
| Float | 48.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.53 |
| Forward PS | 2.82 |
| PB Ratio | 32.98 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.48, with a Debt / Equity ratio of 13.72.
| Current Ratio | 3.48 |
| Quick Ratio | 3.15 |
| Debt / Equity | 13.72 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -28.76 |
Financial Efficiency
Return on equity (ROE) is -210.35% and return on invested capital (ROIC) is -602.38%.
| Return on Equity (ROE) | -210.35% |
| Return on Assets (ROA) | -48.02% |
| Return on Invested Capital (ROIC) | -602.38% |
| Return on Capital Employed (ROCE) | -114.65% |
| Weighted Average Cost of Capital (WACC) | 7.89% |
| Revenue Per Employee | $584,635 |
| Profits Per Employee | -$1.08M |
| Employee Count | 200 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 4.77 |
Taxes
| Income Tax | -80,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.90% in the last 52 weeks. The beta is 1.00, so SPRY's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | -55.90% |
| 50-Day Moving Average | 5.90 |
| 200-Day Moving Average | 8.43 |
| Relative Strength Index (RSI) | 24.99 |
| Average Volume (20 Days) | 1,545,705 |
Short Selling Information
The latest short interest is 23.21 million, so 23.34% of the outstanding shares have been sold short.
| Short Interest | 23.21M |
| Short Previous Month | 22.95M |
| Short % of Shares Out | 23.34% |
| Short % of Float | 48.32% |
| Short Ratio (days to cover) | 12.34 |
Income Statement
In the last 12 months, SPRY had revenue of $116.93 million and -$215.43 million in losses. Loss per share was -$2.18.
| Revenue | 116.93M |
| Gross Profit | 68.22M |
| Operating Income | -216.27M |
| Pretax Income | -215.51M |
| Net Income | -215.43M |
| EBITDA | -214.65M |
| EBIT | -216.27M |
| Loss Per Share | -$2.18 |
Balance Sheet
The company has $143.85 million in cash and $171.60 million in debt, with a net cash position of -$27.76 million or -$0.28 per share.
| Cash & Cash Equivalents | 143.85M |
| Total Debt | 171.60M |
| Net Cash | -27.76M |
| Net Cash Per Share | -$0.28 |
| Equity (Book Value) | 12.51M |
| Book Value Per Share | 0.13 |
| Working Capital | 150.65M |
Cash Flow
In the last 12 months, operating cash flow was -$196.41 million and capital expenditures -$197,000, giving a free cash flow of -$196.60 million.
| Operating Cash Flow | -196.41M |
| Capital Expenditures | -197,000 |
| Depreciation & Amortization | 1.62M |
| Net Borrowing | 96.26M |
| Free Cash Flow | -196.60M |
| FCF Per Share | -$1.98 |
Margins
Gross margin is 58.35%, with operating and profit margins of -184.96% and -184.24%.
| Gross Margin | 58.35% |
| Operating Margin | -184.96% |
| Pretax Margin | -184.31% |
| Profit Margin | -184.24% |
| EBITDA Margin | -183.57% |
| EBIT Margin | -184.96% |
| FCF Margin | n/a |
Dividends & Yields
SPRY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.43% |
| Shareholder Yield | n/a |
| Earnings Yield | -52.20% |
| FCF Yield | -47.64% |
Analyst Forecast
The average price target for SPRY is $22.50, which is 442.17% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $22.50 |
| Price Target Difference | 442.17% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 51.03% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SPRY has an Altman Z-Score of -1.36 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.36 |
| Piotroski F-Score | 1 |